AssetMark Inc
SENT

AssetMark Inc’s AdvisorShares Alpha DNA Equity Sentiment ETF SENT Stock Holding History

AssetMark Inc’s Portfolio SENT Stock Details SENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33
Closed -$745 – 1725
2022
Q4 		$745 Buy
+33
New +$758 ﹤0.01% 1499

Other funds holding SENT

AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
M1FG
Mach-1 Financial Group Rogers, Arkansas $258M AUM 22.48% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
ADIM
Alpha DNA Investment Management Columbia, Maryland $8.98M AUM 26.05% 1-Year Est. Return
IWM
Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
MA
MAS Advisors Miami, Florida $63.2M AUM 9.63% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

AssetMark Inc's SENT Position: Q1 2023 in Review

AssetMark Inc sold out of AdvisorShares Alpha DNA Equity Sentiment ETF (SENT) in Q1 2023, closing a stake of 33 shares — an estimated $745 sold.

AssetMark Inc first reported a position in SENT in Q4 2022 and held it in 1 quarter. The position peaked at $745 in Q4 2022. 9 funds tracked by Wall St. Rank hold SENT as of Q1 2023.

  • AssetMark Inc reported no remaining AdvisorShares Alpha DNA Equity Sentiment ETF position as of Q1 2023 after selling out during the quarter.
  • AssetMark Inc sold 33 AdvisorShares Alpha DNA Equity Sentiment ETF shares in Q1 2023, an estimated $745.
  • AssetMark Inc first reported a position in AdvisorShares Alpha DNA Equity Sentiment ETF in Q4 2022 and held it in 1 quarter.
  • AssetMark Inc's AdvisorShares Alpha DNA Equity Sentiment ETF position peaked at $745 in Q4 2022.
  • 9 funds tracked by Wall St. Rank held AdvisorShares Alpha DNA Equity Sentiment ETF as of Q1 2023.

Based on AssetMark Inc's 13F filing for Q1 2023, filed 5 May 2023.